1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA

Tibbs, M.K.; Zietmant, A.L.; Dallow, K.C.; Althausenz, A.F.; Heney, N.M.; Shipley, William U.

doi:10.1016/0360-3016(95)97841-n

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

1016 Biochemical outcome following external beain radiation therapy for T1–2 prostate carcinoma: the importance of achieving an undetectable nadir PSA

Cited by 11 publications

References 0 publications

Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values <10 ng/ml

Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values <10 ng/ml

Definitive Strahlentherapie des Prostatakarzinoms

Die Bestimmung des PSA-Nadirs nach Strahlentherapie kann die Dosissteigerungsstudie an Patienten mit prätherapeutischen PSA-Werten < 10 ng/ml nicht bestätigen

Contact Info

Product

Resources

About